Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

18
Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD

Transcript of Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Page 1: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Optimizing Tissue Collection for PD Assays Using Non-Clinical

Models

Melinda Hollingshead, DVM, PhD

Page 2: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.
Page 3: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Typical Rodent Sample Collection Methods

• Euthanasia (CO2)

• Tumor resection

• Transfer to tube

• Freeze in dry ice or -70C freezer

• Timing has not traditionally been perceived as crucial

Page 4: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Effect of Sampling Procedures on Protein Levels in Tumors

• Tumors in mice were sampled as follows:– Cryobiopsy + Anesthesia– Resection + Anesthesia– Fine Needle Aspirate (FNA) + Anesthesia

– Resection after CO2 Sacrifice

– Measured ERK, AKT, MEK1/2 & Phospho Proteins

Page 5: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

pAKT SettingsMin 20.0Max 75.01 min exp.

phospho-AKT(Cell Signaling #9271)

Separated on an 8% Tris-Gly Gel

200140

10080

60

50

40

30

FN

A +

An

esth

esia

Cry

ob

iop

sy +

An

esth

esia

Resecti

on

+ A

nesth

esia

Resecti

on

Aft

er

CO

2 S

AC

Cry

ob

iop

sy +

An

esth

esia

Resecti

on

+ A

nesth

esia

FN

A +

An

esth

esia

Resecti

on

Aft

er

CO

2 S

AC

+C

C011 U

ntr

eate

d

Jurk

ats

60 kDa

b-Actin

Actin SettingsMin 20.0

Max 3000.0 30 sec exp.

Comparing All Four Harvest Methods on the Same Gel

Page 6: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

The cryobiopsy device leaves a 10-gauge wound in the

sampled tissue. We sought to reduce the biopsy diameter so we could do repeat samples in

mice and transfer the technique to the clinic.

Page 7: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Dorsal and lateral views of the biopsy needle sample chamber. This chamber is opened by cocking the needle prior to inserting it into the tissue. These biopsy needles are available in a variety of sizes (14-22 gauge).

Page 8: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

So, how are we collecting PD samples from

preclinical efficacy models?

Page 9: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Pre-chill cryovials in liquid nitrogen

Page 10: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

The biopsy needle is cocked to

prepare the sample

collection chamber

Mouse is anesthetized

with isoflurane inhalation anesthetic,

tumor is wiped with disinfectant

Page 11: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

The biopsy is collected

percutaneously or by open exposure

depending upon the

experimental goal

Page 12: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Prechilled tube is withdrawn from liquid nitrogen

Page 13: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Sample is transferred from needle to prechilled cryovial by touching the tumor sample to the inner wall. The

biopsy adheres to the tube and rapidly freezes.

Page 14: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Examples of xenograft tumor biopsies

Page 15: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

• The first two images show frozen sections of excisional biopsies (H&E).

• The third image shows a needle biopsy (H&E).

Inconsistency of Excisional Biopsies

Page 16: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Colo-829 SC Tumors Collected Post Dose 4

Poly-ADP-ribose (Trevigen)Min 20.0

Max 400.04 min exp.

Drug Vehicle Q12h x 5D PO

Mou

se 5

Mou

se 9

Mou

se 1

1

Mou

se 1

3

Mou

se 1

5

Mou

se 1

8

AA

XR

2-7

#1

200140100

80

513

b-Actin

ABT-888 25 mg/kg Q12h x 5D PO

Mou

se 3

Mou

se 7

Mou

se 1

6

Mou

se 1

7

Mou

se 1

9

Mou

se 2

1

AA

XR

2-7

#1

517

Use of Frozen Tumor Samples for Assessing PD

Page 17: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

Summary

• Choice of collection methods can profoundly affect target analysis outcomes

• Mouse xenografts help optimize sample collection and handling protocols

• Comparisons of experimental variables should aid in determining optimum sample handling

• Xenografts provide samples that simulate clinical material during assay development

• Preclinical models can be designed to use/test clinically relevant methods

Page 18: Optimizing Tissue Collection for PD Assays Using Non-Clinical Models Melinda Hollingshead, DVM, PhD.

The Next Speaker is:

Dr. Robert Kinders